MnM helped a leading life sciences consumables company tap into a new revenue opportunity worth $150 Mn over the next 5 years for pharmaceuticals quality control (QC) testing consumables.
Read StoryMany of the changes disrupting traditional healthcare stem from rapid technology advancements, especially in the B2B sectors like biopharmaceuticals and gene sequencing. Our market intelligence helps to make the transition into advanced health system functionality and better efficiency by incorporating imaging solutions, remote patient monitoring, telehealth, smart pills and medical wearables into current healthcare practices.